Addus HomeCare Co. (NASDAQ:ADUS) Shares Sold by Los Angeles Capital Management LLC

Los Angeles Capital Management LLC trimmed its stake in Addus HomeCare Co. (NASDAQ:ADUS) by 13.3% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 9,132 shares of the company’s stock after selling 1,403 shares during the quarter. Los Angeles Capital Management LLC owned approximately 0.06% of Addus HomeCare worth $944,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Principal Securities Inc. acquired a new position in Addus HomeCare in the 4th quarter valued at about $26,000. GAMMA Investing LLC acquired a new position in shares of Addus HomeCare in the fourth quarter valued at approximately $34,000. Assetmark Inc. lifted its stake in shares of Addus HomeCare by 33.3% during the fourth quarter. Assetmark Inc. now owns 1,774 shares of the company’s stock valued at $165,000 after buying an additional 443 shares during the period. DekaBank Deutsche Girozentrale acquired a new stake in Addus HomeCare during the third quarter worth approximately $189,000. Finally, Envestnet Portfolio Solutions Inc. purchased a new stake in Addus HomeCare in the 4th quarter worth approximately $214,000. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

Addus HomeCare Stock Up 0.8 %

Shares of Addus HomeCare stock opened at $119.39 on Tuesday. Addus HomeCare Co. has a twelve month low of $78.35 and a twelve month high of $120.31. The stock has a market cap of $1.95 billion, a price-to-earnings ratio of 29.63, a price-to-earnings-growth ratio of 2.23 and a beta of 1.02. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.14. The company has a fifty day moving average price of $108.06 and a 200 day moving average price of $99.31.

Addus HomeCare (NASDAQ:ADUS) last posted its earnings results on Monday, May 6th. The company reported $1.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.97 by $0.24. The business had revenue of $280.70 million during the quarter, compared to analyst estimates of $279.49 million. Addus HomeCare had a return on equity of 10.03% and a net margin of 6.04%. The company’s revenue for the quarter was up 11.6% compared to the same quarter last year. During the same quarter last year, the firm earned $0.84 earnings per share. Equities research analysts forecast that Addus HomeCare Co. will post 4.36 earnings per share for the current fiscal year.

Insider Transactions at Addus HomeCare

In related news, EVP Roberton James Stevenson sold 217 shares of Addus HomeCare stock in a transaction on Monday, June 17th. The shares were sold at an average price of $116.13, for a total transaction of $25,200.21. Following the sale, the executive vice president now owns 10,217 shares of the company’s stock, valued at approximately $1,186,500.21. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 4.60% of the company’s stock.

Analyst Upgrades and Downgrades

ADUS has been the topic of several analyst reports. Barclays cut Addus HomeCare from an “equal weight” rating to an “underweight” rating and set a $83.00 price objective on the stock. in a report on Tuesday, April 23rd. TD Cowen lifted their price target on Addus HomeCare from $119.00 to $128.00 and gave the company a “buy” rating in a report on Tuesday, June 18th. Bank of America increased their price objective on shares of Addus HomeCare from $115.00 to $118.00 and gave the stock a “buy” rating in a report on Tuesday, May 7th. Stephens boosted their target price on shares of Addus HomeCare from $120.00 to $128.00 and gave the company an “overweight” rating in a report on Friday, May 31st. Finally, StockNews.com lowered shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research report on Friday. One investment analyst has rated the stock with a sell rating and eight have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $113.43.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.